Clinical impact of point-of-care vs laboratory measurement of anticoagulation

American Journal of Clinical Pathology

Volumn 123, Issue 2, 2005, Pages 184-188

  Sunderji, Rubina ^a,b   Gin, Kenneth ^a,b   Shalansky, Karen ^a,b   Carter, Cedric ^a,b   Chambers, Keith ^a   Davies, Cheryl ^a   Schwartz, Linda ^c   Fung, Anthony ^a,b  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Evergreen House   (Canada)

Author keywords

Anticoagulation; International normalized ratio; Point of care; Self management; Self testing; Warfarin

Indexed keywords

REAGENT; WARFARIN;

ACCURACY; ADULT; AGED; ANTICOAGULATION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; FEMALE; HOSPITAL INFORMATION SYSTEM; HOSPITAL LABORATORY; HUMAN; INSTRUMENT; INTERNATIONAL NORMALIZED RATIO; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PERFORMANCE; PERSONAL MONITOR; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL;

EID: 13244262810     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/P2Y3VM4AXPVUDAW3     Document Type: Article

References (18)

1. Kortke H, Korfer R. International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous? Ann Thorac Surg. 2001;72:44-48.
2. Sawicki PT. A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. JAMA. 1999;281:145-150.
3. Cromheecke ME, Levi M, Colly LP, et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet. 2000;356:97-102.
4. Horstkotte D, Piper C, Wiemer M, et al. Improvement of prognosis by home prothrombin estimation in patients with life long anticoagulation therapy [abstract]. Eur Heart J. 1996;17(suppl):S230.
5. Fitzmaurice DA, Machin SJ, on behalf of the British Society of Haematology Task Force for Haemostasis and Thrombosis. Recommendations for patients undertaking self-management of oral anticoagulation. BMJ. 2001;323:985-989.
6. Kaatz SS, White RH, Hill J, et al. Accuracy of laboratory and portable monitor international normalized ratio determinations. Arch Intern Med. 1995;155:1861-1867.
7. Sunderji R, Fung A, Gin K, et al. Patient self-management of oral anticoagulation: a review. Can J Cardiol. 2003;19:931-935.
8. Sunderji R, Gin K, Shalansky K, et al. A randomized trial of patient self-managed versus physician-managed oral anticoagulation. Can J Cardiol. 2004;20:1117-1123.
9. Sunderji R, Campbell L, Shalansky K, et al. Outpatient self-management of warfarin therapy: a pilot study. Pharmacotherapy. 1999;19:787-793.
10. Lassen JF, Brandslund I, Antonsen S. International normalized ratio for prothrombin times in patients taking oral anticoagulants: critical difference and probability of significant change in consecutive measures. Clin Chem. 1995;42:444-447.
11. Oral Anticoagulation Monitoring Study Group. Prothrombin measurement using a patient self-testing system. Am J Clin Pathol. 2001;115:280-287.
12. Shermock KM, Bragg L, Connor JT, et al. Differences in warfarin dosing decisions based on international normalized ratio measurements with two point-of-care testing devices and a reference laboratory measurement. Pharmacotherapy. 2002;22:1397-1404.
13. Pierce MT, Crain L, Smith J, et al. Point-of-care versus laboratory measurement of the international normalized ratio. Am J Health Syst Pharm. 2000;57:2271-2274.
14. Lind SE, Pearce LA, Feinberg WM, et al, for the SPAF Investigators. Clinically significant differences in the international normalized ratio measured with reagents of different sensitivities. Blood Coagul Fibrinolysis. 1999;10:215-217.
15. Chapman DC, Stephens MA, Hamann GL, et al. Accuracy, clinical correlation, and patient acceptance of two handheld prothrombin time monitoring devices in the ambulatory setting. Ann Pharmacother. 1999;33:775-780.
16. Reed C, Rickman H. Accuracy of international normalized ratio determined by portable whole-blood coagulation monitor versus a central laboratory. Am J Health Syst Pharm. 1999;56:1619-1623.
17. Ansell J, Hirsh J, Dalen J, et al. Managing oral anticoagulant therapy. Chest. 2001;119(suppl):S22-S38.
18. Oral Anticoagulation Monitoring Study Group. Point-of-care prothrombin time measurement for professional and patient self-testing use: a multicenter clinical experience. Am J Clin Pathol. 2001;115:288-296.